FDA proposes biosimilars approval pathway
Tuesday, February 14, 2012 - 09:30
in Health & Medicine
US biotechnology industry cautiously welcomes FDA’s draft guidance to facilitate biosimilars development and approval
US biotechnology industry cautiously welcomes FDA’s draft guidance to facilitate biosimilars development and approval